20-Apr-2021 | Market Research Store

Findings from Market Research Store report “By Drug Type (Antibiotics, Anaesthetic, Nonsteroidal anti-Inflammatory drug, Analgesic), By Formulation (Topical, and Oral), and By End User (Hospitals, Online pharmacies, and Retail pharmacies): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global demand for Acute Otitis Media Treatment market in 2019 was approximately USD 2,100 Million. The market is anticipated to grow at a CAGR of 5% and is anticipated to reach around USD 3,000 Million by 2026.

Acute otitis media is the most common ear infection in children since the Eustachian tube is shorter in children than in adults, making bacteria and viruses more available. Bacteria including strep and H. flu contribute to around 85 percent of AOM outbreaks, while viruses contribute to just 15%. AOM is an ear infection in which the air-filled area behind the eardrum (the middle ear) becomes irritated, causing discomfort as well as other signs of illness such as fever, irritability, and sleeping difficulties. Antibiotics are also the first line of treatment for acute otitis media. If antibiotics do not function, analgesics and antipyretics are recommended for the treatment of acute otitis media. Antihistamines and decongestants are prescribed by the physician for the treatment of acute otitis media in a few patients. A person's hearing loss/impairment, intracranial infection, and facial paralysis may all occur as a result of prolonged acute otitis media episodes. Children aged 6 to 18 months have a high chance of contracting the disease. If left untreated, the disease can lead to permanent hearing loss.

According to a report published in the Formulary Journal in 2014, AOM accounted for about USD 314 per child per year in healthcare expenditure in the United States, amounting to an additional USD 2.88 billion in healthcare expenditure. Furthermore, the development of strict guidelines and recommendations for the treatment of AOM in children by numerous governmental and non-governmental bodies is expected to be a factor in the industry's growth.

According to a study published in the South African Medical Journal in 2014, the global prevalence rate of acute otitis media (AOM) is 10.9 percent, with 80 percent of children experiencing at least one episode before the age of three. The global acute otitis media care and management market are being driven by an increase in the number of cases of acute otitis media. Other factors that contribute to an increase in the number of acute otitis media cases include an increase in maternal age, children of aboriginal descent, and the number of women who smoke during pregnancy. Acute otitis media treatment will also rise due to the availability of generic drugs at a lower cost than branded drugs for acute otitis media treatment. The launch of novel drugs for the treatment of acute otitis media by leading pharmaceutical companies will fuel the acute otitis media treatment market's rise. Antibiotic resistance strains are emerging as a result of the widespread use of antibiotics to treat acute otitis media, limiting the use of such medications in the treatment of the disease. The demand for acute otitis media care and management is hindered as a result of this.

Because of the high availability of novel drugs for acute otitis media treatment in the United States and Canada, North America is projected to dominate the acute otitis media treatment market by revenue share. In less developed and underdeveloped countries, poor hygiene services, a lack of healthcare systems, and a lack of understanding are the leading causes of acute media otitis. The prevalence of acute otitis media is high in Middle Eastern countries. The disease affects a large number of children in Saudi Arabia. The disease is very common in less developed countries, and it is one of the leading causes of childhood mortality.

Browse the full Acute Otitis Media Treatment Market By Drug Type (Antibiotics, Nonsteroidal Anti-Inflammatory Drug, Analgesic, and Anaesthetic), By Formulation (Topical and Oral), By End User (Food Hospitals, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026.” Report at https://www.marketresearchstore.com/market-insights/acute-otitis-media-treatment-market-828578

Some of the key players in the acute otitis media treatment market are Eli Lilly and Company, Takeda Pharmaceuticals, Pfizer, Inc., Teva Pharmaceuticals, Abbott, AstraZeneca plc, GlaxoSmithKline plc, Johnson and Johnson, Janssen, Pharmaceuticals, Squibb Company, Sanofi, Bristol Myers, Bayer AG, Astellas Pharma, Inc., and Novartis AG, among others.

Alcon's DROPS101 Online Tools, a mobile platform that offers educational resources about widely prescribed ear and eye treatments, was launched in 2013. DROPS101 Web Tools provides product details for acute otitis media care. Aurobindo Pharma Ltd. obtained FDA approval in 2015 to market its generic antibiotic Cefixime in the United States. Cefixime is a cephalosporin of the third generation that is used to treat acute otitis media. OTOVEL was founded in 2016 by Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC (ciprofloxacin 0.3 percent and fluocinolone acetonide 0.025 percent ). This solution is used to treat pediatric patients with acute otitis media with tympanostomy tubes (AOMT). Also, Otonomy, Inc. released OTIPRIO (ciprofloxacin otic suspension) in 2016, which is indicated for the treatment of pediatric patients. Besides, Otonomy, Inc. released OTIPRIO (ciprofloxacin otic suspension) in the United States in 2016, which is indicated for the treatment of pediatric patients with bilateral acute otitis media.

This report segments the acute otitis media treatment market as follows:

Global Acute Otitis Media Treatment Market: By Drug Type Segmentation Analysis:

  • Antibiotics
  • Anaesthetic
  • Nonsteroidal anti-Inflammatory drug
  • Analgesic

Global Acute Otitis Media Treatment Market: By Formulation Segmentation Analysis

  • Topical
  • Oral

Global Acute Otitis Media Treatment Market: By End Use Segmentation Analysis

  • Industrial
  • Retail

Global Acute Otitis Media Treatment Market: By End User Segmentation Analysis

  • Hospitals
  • Online pharmacies
  • Retail pharmacies
  • Others

Global Acute Otitis Media Treatment Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Market Research Store is a single destination for all types of industries, global, and regional reports. We feature large repository of latest industry reports and market statistics published by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available. Our vast database of reports enables our clients to benefit from expert insights on global industries, products, and market trends.

Contact Us:

Market Research Store
244 Fifth Avenue, Suite N202
New York, 10001, United States
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@MarketResearchStore.com
Website: https://www.marketresearchstore.com